The Necroptotic Process-Related Signature Predicts Immune Infiltration and Drug Sensitivity in Kidney Renal Papillary Cell Carcinoma

Wenfeng Lin; Ruizhi Xue; Hideo Ueki; Peng Huang

doi:10.2174/0115680096286503240321040556

The Necroptotic Process-Related Signature Predicts Immune Infiltration and Drug Sensitivity in Kidney Renal Papillary Cell Carcinoma

Curr Cancer Drug Targets. 2024 Apr 8. doi: 10.2174/0115680096286503240321040556. Online ahead of print.

Authors

Wenfeng Lin^{1

2}, Ruizhi Xue^{1

3}, Hideo Ueki¹, Peng Huang^{1

4}

Affiliations

¹ Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
² Department of Urology, Affiliated Qingyuan Hospital, Guangzhou Medical University, Qingyuan People's Hospital, Qingyuan, China.
³ Department of Urology, Xiangya Hospital, Central South University, Changsha, China.
⁴ Neutron Therapy Research Center (NTCR), Okayama University, Okayama, Japan.

PMID: 38616744
DOI: 10.2174/0115680096286503240321040556

Abstract

Background: It remains controversial whether the current subtypes of kidney renal papillary cell carcinoma (KIRP) can be used to predict the prognosis independently.

Objective: This observational study aimed to identify a risk signature based on necroptotic pro-cess-related genes (NPRGs) in KIRP.

Methods: In the training cohort, LASSO regression was applied to construct the risk signature from 158 NPRGs, followed by the analysis of Overall Survival (OS) using the Kaplan-Meier method. The signature accuracy was evaluated by the Receiver Operating Characteristic (ROC) curve, which was further validated by the test cohort. Wilcoxon test was used to compare the expressions of immune-related genes, neoantigen genes, and immune infiltration between differ-ent risk groups, while the correlation test was performed between NPRGs expressions and drug sensitivity. Gene set enrichment analysis was used to investigate the NPRGs' signature's biologi-cal functions.

Results: We finally screened out 4-NPRGs (BIRC3, CAMK2B, PYGM, and TRADD) for con-structing the risk signature with the area under the ROC curve (AUC) reaching about 0.8. The risk score could be used as an independent OS predictor. Consistent with the enriched signaling, the NPRGs signature was found to be closely associated with neoantigen, immune cell infiltration, and immune-related functions. Based on NPRGs expressions, we also predicted multiple drugs potentially sensitive or resistant to treatment.

Conclusion: The novel 4-NPRGs risk signature can predict the prognosis, immune infiltration, and therapeutic sensitivity of KIRP.

Keywords: Necroptosis; drug sensitivity; gene signature; immune infiltration; kidney renal papillary cell carcinoma.; prognosis.